Page last updated: 2024-11-02

pd 153035 and Palmoplantaris Pustulosis

pd 153035 has been researched along with Palmoplantaris Pustulosis in 2 studies

4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thacher, SM1
Vasudevan, J1
Tsang, KY1
Nagpal, S1
Chandraratna, RA1
Sugiura, K1
Muro, Y1
Futamura, K1
Matsumoto, K1
Hashimoto, N1
Nishizawa, Y1
Nagasaka, T1
Saito, H1
Tomita, Y1
Usukura, J1

Reviews

1 review available for pd 153035 and Palmoplantaris Pustulosis

ArticleYear
New dermatological agents for the treatment of psoriasis.
    Journal of medicinal chemistry, 2001, Feb-01, Volume: 44, Issue:3

    Topics: Administration, Topical; Anti-Inflammatory Agents; Cholecalciferol; Clinical Trials as Topic; Glucoc

2001

Other Studies

1 other study available for pd 153035 and Palmoplantaris Pustulosis

ArticleYear
The unfolded protein response is activated in differentiating epidermal keratinocytes.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; ATP-Binding Cassette Transporters; Carcinoma, Squamous C

2009